Comparative effectiveness of propafenone and aksaritmin for conversion of paroxysmal atrial fibrillation
Husniddin KuchkarovRepublican Specialized Scientific Practical Medical Center of Cardiology, Tashkent, UzbekistanН. У. ЗакировRepublican Specialized Scientific Practical Medical Center of Cardiology, Tashkent, UzbekistanSh.K.AzizovRepublican Specialized Scientific Practical Medical Center of Cardiology, Tashkent, UzbekistanO.S.SalayevRepublican Specialized Scientific Practical Medical Center of Cardiology, Tashkent, UzbekistanD IrisovRepublican Specialized Scientific Practical Medical Center of Cardiology, Tashkent, Uzbekistan
ABI
Abstract
Atrial fibrillation (AF) is one of the most common forms of arrhythmias, occurring in the general population in up to 2% of cases. The probability of the development of AF increases with age. AF is detected in 3.8% of individuals older than 60 years and in 9% of people older than 80 years [1]. AF is the cause of 20–30% of all strokes [2, 3]. In addition, undiagnosed ("silent") AF may be the cause of some cases of "cryptogenic" strokes [4, 5]. Paroxysmal AF increases the risk of stroke to the same degree as other forms of AF (persistent or permanent) [6].
Topics
Identifiers
Citations and references
Cited by 00 references